129 related articles for article (PubMed ID: 25720568)
1. Hepatic estrogen receptor α improves hepatosteatosis through upregulation of small heterodimer partner.
Wang X; Lu Y; Wang E; Zhang Z; Xiong X; Zhang H; Lu J; Zheng S; Yang J; Xia X; Yang S; Li X
J Hepatol; 2015 Jul; 63(1):183-90. PubMed ID: 25720568
[TBL] [Abstract][Full Text] [Related]
2. Defective FXR-SHP Regulation in Obesity Aberrantly Increases
Seok S; Sun H; Kim YC; Kemper B; Kemper JK
Diabetes; 2021 Mar; 70(3):733-744. PubMed ID: 33328206
[TBL] [Abstract][Full Text] [Related]
3. A selective estrogen receptor α agonist ameliorates hepatic steatosis in the male aromatase knockout mouse.
Chow JD; Jones ME; Prelle K; Simpson ER; Boon WC
J Endocrinol; 2011 Sep; 210(3):323-34. PubMed ID: 21705395
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor alpha regulates expression of the orphan receptor small heterodimer partner.
Lai K; Harnish DC; Evans MJ
J Biol Chem; 2003 Sep; 278(38):36418-29. PubMed ID: 12842887
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-Induced Cholestasis Leads to Repressed CYP2D6 Expression in CYP2D6-Humanized Mice.
Pan X; Jeong H
Mol Pharmacol; 2015 Jul; 88(1):106-12. PubMed ID: 25943116
[TBL] [Abstract][Full Text] [Related]
6. Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice.
Lu Y; Ma Z; Zhang Z; Xiong X; Wang X; Zhang H; Shi G; Xia X; Ning G; Li X
Gut; 2014 Jan; 63(1):170-8. PubMed ID: 23348961
[TBL] [Abstract][Full Text] [Related]
7. Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice.
Kim KH; Choi S; Zhou Y; Kim EY; Lee JM; Saha PK; Anakk S; Moore DD
Hepatology; 2017 Aug; 66(2):498-509. PubMed ID: 28378930
[TBL] [Abstract][Full Text] [Related]
8. Ablation of IFNγ in myeloid cells suppresses liver inflammation and fibrogenesis in mice with hepatic small heterodimer partner (SHP) deletion.
Zhu L; Litts B; Wang Y; Rein JA; Atzrodt CL; Chinnarasu S; An J; Thorson AS; Xu Y; Stafford JM
Mol Metab; 2024 May; 83():101932. PubMed ID: 38589002
[TBL] [Abstract][Full Text] [Related]
9. Cholesteryl ester transfer protein alters liver and plasma triglyceride metabolism through two liver networks in female mice.
Palmisano BT; Le TD; Zhu L; Lee YK; Stafford JM
J Lipid Res; 2016 Aug; 57(8):1541-51. PubMed ID: 27354419
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver.
Huang J; Iqbal J; Saha PK; Liu J; Chan L; Hussain MM; Moore DD; Wang L
Hepatology; 2007 Jul; 46(1):147-57. PubMed ID: 17526026
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
13. Selective Activation of Estrogen Receptor α Activation Function-1 Is Sufficient to Prevent Obesity, Steatosis, and Insulin Resistance in Mouse.
Guillaume M; Handgraaf S; Fabre A; Raymond-Letron I; Riant E; Montagner A; Vinel A; Buscato M; Smirnova N; Fontaine C; Guillou H; Arnal JF; Gourdy P
Am J Pathol; 2017 Jun; 187(6):1273-1287. PubMed ID: 28502695
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice.
Zhang ZC; Liu Y; Xiao LL; Li SF; Jiang JH; Zhao Y; Qian SW; Tang QQ; Li X
J Hepatol; 2015 Dec; 63(6):1466-75. PubMed ID: 26272872
[TBL] [Abstract][Full Text] [Related]
15. Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function.
Milona A; Owen BM; Cobbold JF; Willemsen EC; Cox IJ; Boudjelal M; Cairns W; Schoonjans K; Taylor-Robinson SD; Klomp LW; Parker MG; White R; van Mil SW; Williamson C
Hepatology; 2010 Oct; 52(4):1341-9. PubMed ID: 20842631
[TBL] [Abstract][Full Text] [Related]
16. Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression.
Cheng D; Xu X; Simon T; Boudyguina E; Deng Z; VerHague M; Lee AH; Shelness GS; Weinberg RB; Parks JS
J Biol Chem; 2016 Nov; 291(45):23793-23803. PubMed ID: 27655915
[TBL] [Abstract][Full Text] [Related]
17. SRY-Box Containing Gene 4 Promotes Liver Steatosis by Upregulation of SREBP-1c.
Jiao Y; Zhao J; Zhang Z; Li M; Yu X; Yang Y; Liu J; Liao S; Li D; Wang Y; Zhang D; Chen Y; Shi G; Liu B; Lu Y; Li X
Diabetes; 2018 Nov; 67(11):2227-2238. PubMed ID: 30181160
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice.
Han SI; Komatsu Y; Murayama A; Steffensen KR; Nakagawa Y; Nakajima Y; Suzuki M; Oie S; Parini P; Vedin LL; Kishimoto H; Shimano H; Gustafsson JÅ; Yanagisawa J
Hepatology; 2014 May; 59(5):1791-802. PubMed ID: 24277692
[TBL] [Abstract][Full Text] [Related]
19. Gender matters: estrogen receptor alpha (ERα) and histone deacetylase (HDAC) 1 and 2 control the gender-specific transcriptional regulation of human uridine diphosphate glucuronosyltransferases genes (UGT1A).
Kalthoff S; Winkler A; Freiberg N; Manns MP; Strassburg CP
J Hepatol; 2013 Oct; 59(4):797-804. PubMed ID: 23714156
[TBL] [Abstract][Full Text] [Related]
20. FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c.
Wang L; Zhu X; Sun X; Yang X; Chang X; Xia M; Lu Y; Xia P; Yan H; Bian H; Gao X
Lipids Health Dis; 2019 Nov; 18(1):197. PubMed ID: 31729980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
